阿根廷布宜诺斯艾利斯市疫苗犹豫的患病率与决定因素:一项概率家庭调查
该研究于2025年4–6月在阿根廷布宜诺斯艾利斯市开展分层多阶段概率家庭调查,共纳入1934户,使用文化适应版疫苗犹豫量表。严格疫苗犹豫加权患病率为7.1%(95%CI:5.8–8.6),扩展疫苗犹豫为24.1%(95%CI:21.8–26.5)。疫苗信心较低是两种定义下最一致的关联因素。
要点
- 严格疫苗犹豫(明确拒绝推荐疫苗)加权患病率为7.1%。
- 扩展疫苗犹豫(含拒绝及因可及性等延迟接种)加权患病率为24.1%。
- 疫苗信心较低与严格和扩展疫苗犹豫均独立相关。
核心结论
- 明确拒绝疫苗不常见,但与延迟和可及障碍相关的更广泛犹豫形式影响相当比例家庭。
- 疫苗信心是跨两种犹豫定义最一致的关联因素。
研究设计与样本
- 2025年4–6月在阿根廷布宜诺斯艾利斯市开展基于人群的研究,采用嵌入官方定期家庭调查的分层多阶段概率抽样设计。
- 使用文化适应版疫苗犹豫量表并进行心理测量学评价,共调查1934户,分析考虑抽样权重、分层和初级抽样单元。
主要发现
- 严格疫苗犹豫加权患病率为7.1%(95%CI:5.8–8.6)。
- 女性受访者性别(调整OR 2.77;95%CI:1.68–4.57)和较低疫苗信心(调整OR 4.19;95%CI:2.65–6.64)与严格疫苗犹豫独立相关。
- 扩展疫苗犹豫加权患病率为24.1%(95%CI:21.8–26.5)。
- 较低疫苗信心(调整OR 2.10;95%CI:1.61–2.74)、女性受访者性别(调整OR 1.33;95%CI:1.03–1.74)、较年轻年龄和居住在非正式定居点(调整OR 2.00;95%CI:1.30–3.08)与扩展疫苗犹豫独立相关。
临床怎么用
- 在公共卫生监测中可同时评估严格拒绝和因可及性、便利性或组织障碍导致的延迟接种。
- 针对疫苗信心较低人群和居住于非正式定居点者设计干预可能有助于降低扩展疫苗犹豫。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vaccine hesitancy represents a growing challenge for immunization programs worldwide. In Latin America, population-based estimates derived from probabilistic surveys remain scarce, limiting the design of evidence-informed interventions. METHODS: We conducted a population-based study in the City of Buenos Aires, Argentina, between April and June 2025 using a stratified multistage probabilistic sampling design embedded within an official periodic household survey. A culturally adapted version of the Vaccine Hesitancy Scale was administered and psychometrically evaluated. Household-level vaccine hesitancy was assessed using two complementary outcomes: strict hesitancy, defined as explicit refusal of recommended vaccines, and extended hesitancy, defined as a broader programmatic outcome combining refusal and reported vaccination delays related to access, convenience, or organizational barriers. Analyses accounted for sampling weights, strata, and primary sampling units. RESULTS: A total of 1934 households were surveyed. The weighted prevalence of strict vaccine hesitancy was 7.1% (95% CI: 5.8-8.6).Female respondent sex (adjusted OR 2.77; 95% CI: 1.68-4.57) and lower vaccine confidence (adjusted OR 4.19; 95% CI: 2.65-6.64) were independent associated with strict vaccine hesitancy. The weighted prevalence of extended vaccine hesitancy was 24.1% (95% CI: 21.8-26.5). Lower vaccine confidence (adjusted OR 2.10; 95% CI: 1.61-2.74), female respondent sex (adjusted OR 1.33; 95% CI: 1.03-1.74), younger age, and residence in informal settlements (adjusted OR 2.00; 95% CI: 1.30-3.08) were independently associated with extended hesitancy. CONCLUSIONS: Outright vaccine refusal was uncommon, but broader forms of hesitancy linked to delays and access barriers affected a substantial proportion of households. Vaccine confidence was the most consistent correlate across definitions.
引用
- Angeleri P, Biscayart C, Ferrante D, et al. Prevalence and determinants of vaccine hesitancy in the City of Buenos Aires, Argentina: A probabilistic household survey. Vaccine. 2026. PMID: 42603507. doi:10.1016/j.vaccine.2026.129045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。